Neogen posts strong Q1 results, beats forecasts and lifts FY2027 outlook
Neogen reported adjusted earnings of $0.08 per share, surpassing the $0.05 consensus. Revenue reached $222.8 million, a 6.5% year‑over‑year increase. The company raised its fiscal 2027 revenue target to $885‑$890 million and its adjusted EBITDA outlook to $181‑$183 million. It also announced a strategic partnership and equity investment with Hinalea Imaging Corp to develop hyperspectral food‑safety imaging.
Why it matters
The earnings beat and higher guidance suggest stronger cash generation, which could support further dividend or buy‑back opportunities, according to the company’s press release. Analysts note that the raised outlook may lift the stock’s valuation as investors price in accelerated growth.
Key facts
- 1Adjusted earnings per share were $0.08, exceeding the $0.05 consensus by about 60%. investing.com
- 2Quarterly revenue was $222.8 million, up 6.5% from the prior year. seekingalpha.com
- 3Fiscal 2027 revenue guidance was increased to a range of $885 million to $890 million. investing.com
- 4Adjusted EBITDA guidance for fiscal 2027 was lifted to $181 million‑$183 million. investing.com
- 5Free cash flow for the quarter amounted to $4.7 million. seekingalpha.com
- 6Neogen entered a strategic collaboration and equity investment with Hinalea Imaging Corp to create hyperspectral imaging solutions for food safety. investing.com
Summary written by AlphAI from 7 of 7 sources. Not investment advice. Figures are as stated by the linked sources.